BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1623575)

  • 1. Pharmacotherapy in shock syndromes: the neglected field of pharmacokinetics and pharmacodynamics.
    Neugebauer E; Dietrich A; Lechleuthner A; Bouillon B; Eypasch E
    Circ Shock; 1992 Apr; 36(4):312-20. PubMed ID: 1623575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in pharmacokinetics and pharmacodynamics.
    Beierle I; Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):529-47. PubMed ID: 10584975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Principles and perspectives of clinical pharmacology].
    Kaufmann W
    Klin Wochenschr; 1991; 69 Suppl 26():8-12. PubMed ID: 1813734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic concepts of clinical pharmacokinetics.
    Raghuram TC; Krishnaswamy K
    J Assoc Physicians India; 1992 Jan; 40(1):29-35. PubMed ID: 1634460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics/pharmacodynamics in drug development: an industrial perspective.
    Chaikin P; Rhodes GR; Bruno R; Rohatagi S; Natarajan C
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1428-38. PubMed ID: 11185663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological rhythms and medications: a source of variability often neglected in pharmacology].
    Bruguerolle B
    Ann Pharm Fr; 2008 Jun; 66(3):185-90. PubMed ID: 18706347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic concepts in pharmacology: important terms in pharmacodynamics and pharmacokinetics].
    Singer E
    Onkologie; 2008; 31 Suppl 2():21-4. PubMed ID: 18487864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological basis of treatment with high dose corticosteroids in circulatory shock.
    Lundberg D
    Acta Chir Scand Suppl; 1985; 526():7-12. PubMed ID: 3867207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of pharmacokinetic-pharmacodynamic relationships in drug development].
    Bellissant E; Courcier-Duplantier S; Blin O;
    Therapie; 2002; 57(4):347-57. PubMed ID: 12422555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial treatment length optimization with an emphasis on disease progression studies.
    Hennig S; Nyberg J; Hooker AC; Karlsson MO
    J Clin Pharmacol; 2009 Mar; 49(3):323-35. PubMed ID: 19246730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy in childhood: what has been done and what has to be done?
    Bartels H
    Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of intravenously administered anesthetic drugs: concepts and lessons for drug development.
    Kern SE; Stanski DR
    Clin Pharmacol Ther; 2008 Jul; 84(1):153-7. PubMed ID: 18463623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic modeling in drug research and development.
    Derendorf H; Lesko LJ; Chaikin P; Colburn WA; Lee P; Miller R; Powell R; Rhodes G; Stanski D; Venitz J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1399-418. PubMed ID: 11185661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of artificial neural networks to clinical pharmacology.
    Brier ME; Aronoff GR
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):510-4. PubMed ID: 8937935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of pharmacokinetics and pharmacodynamics.
    Scharf S; Christophidis N
    Med J Aust; 1993 Mar; 158(6):395-402. PubMed ID: 8479353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.